How do I initiate and titrate a noradrenaline (norepinephrine) infusion in a hypotensive patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Infusion Protocol for Hypotension in a 70-Year-Old Male

For a hypotensive 70-year-old male patient, prepare norepinephrine by adding one ampoule (4 mg) to 50 mL of 5% dextrose solution, start at 2-4 mcg/minute, and titrate every 5 minutes based on blood pressure response, targeting a MAP of 65-100 mmHg. 1, 2

Preparation of Norepinephrine Infusion

  • Add one ampoule (4 mg) of norepinephrine to 50 mL of 5% dextrose solution to produce a concentration of 80 mcg/mL 1
  • Use 5% dextrose solution rather than normal saline alone as dextrose reduces loss of potency due to oxidation 1
  • Administer through a central venous line whenever possible to prevent tissue necrosis from extravasation 2
  • If central access is not immediately available, use a large peripheral vein with a large-bore cannula while central access is being established 3

Initial Dosing and Administration

  • Start with an initial dose of 2-4 mcg/minute (1.5-3 mL/hour of the 80 mcg/mL solution) 1
  • For severe hypotension (systolic BP ≤70 mmHg), consider starting at 8-12 mcg/minute (6-9 mL/hour) 1
  • Always address hypovolemia before or concurrently with norepinephrine administration 1, 2
  • Monitor blood pressure every 2 minutes until desired hemodynamic effect is achieved 1

Titration Protocol

  • Once target blood pressure is achieved, monitor blood pressure every 5 minutes 1
  • Typical maintenance dose ranges from 2-4 mcg/minute 1
  • Titrate to achieve a target mean arterial pressure (MAP) of 65-100 mmHg 2
  • For this elderly patient, consider targeting the lower end of the range (MAP 65-75 mmHg) to avoid excessive vasoconstriction 4
  • If blood pressure remains inadequate despite increasing doses, consider adding a second vasopressor agent 5

Monitoring During Infusion

  • Continuous hemodynamic monitoring is essential during administration 2
  • Monitor for signs of extravasation; if it occurs, infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the site 2, 5
  • Watch for cardiac arrhythmias, especially in patients with underlying heart disease 2
  • Monitor urine output as an indicator of adequate renal perfusion 6
  • Assess peripheral perfusion regularly (skin temperature, capillary refill) 5

Weaning Protocol

  • Once the patient is hemodynamically stable, reduce the flow rate gradually 1
  • Avoid abrupt withdrawal as this may result in marked hypotension 1
  • Decrease by 25% of the current dose every 30 minutes as tolerated 5

Special Considerations for Elderly Patients

  • Elderly patients may be at greater risk of developing adverse reactions to norepinephrine 1
  • Use cautiously in patients with ischemic heart disease as it may increase myocardial oxygen requirements 2
  • Higher doses (>10 mcg/minute) are associated with increased mortality and should be avoided if possible 5, 2
  • Norepinephrine may actually improve renal blood flow in hypotensive states, contrary to traditional concerns 2, 6

Potential Complications and Management

  • Excessive vasoconstriction leading to end-organ hypoperfusion 2
  • Tissue necrosis if extravasation occurs - treat immediately with phentolamine 2
  • Cardiac arrhythmias, especially at higher doses 2
  • Increased myocardial oxygen consumption potentially worsening ischemia 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.